OGT delivers superior MRD detection capabilities with new SureSeq Myeloid MRD Panel
January 22, 2025
New York, USA -- Today, OGT announces the North American launch of its new next-generation sequencing (NGS) SureSeq™ Myeloid MRD Panel, which provides a flexible NGS workflow for the detection of ultra-low frequency measurable residual disease (MRD)-associated biomarkers in acute myeloid leukemia (AML). This ultra-sensitive NGS panel leverages OGT’s expertise in hybrid capture to enhance the detection [...]
EVIDENT Launches New Global Website
January 22, 2025
Consolidated platform delivers dynamic, engaging user experience WALTHAM, Mass. — Evident announces the launch of its new global website at EvidentScientific.com. Powered by best-in-class technology, the new site is designed to enhance the Evident online experience, perform seamlessly across all devices and provide critical information quickly and efficiently. By consolidating multiple company sites into a [...]
Novilytic Enters Exclusive Distribution Partnership With Avantor
January 22, 2025
WEST LAFAYETTE, Ind. – Novilytic, an innovator in molecular recognition technology, is proud to announce an exclusive distribution partnership with Avantor, a global supplier of discovery-to-delivery solutions and the parent company of VWR. Effective immediately, this strategic partnership will make Novilytic’s Proteometer® platform – including the Proteometer-L, Proteometer-UFT, and the upcoming Proteometer-CV readily accessible to [...]
January 22, 2025
Award Advances Critical Work That Started in 2018 INDIANAPOLIS – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, along with the Indiana University School of Medicine, have been awarded a prestigious grant from the National Cancer Institute totaling $2.5 million over a five-year period to increase critical leukemia and lymphoma testing [...]
Defined hydrogel enables reproducible culture of cancer cells in xenograft models.
January 22, 2025
AMSBIO has launched MatriMix for PDX, a fully defined extracellular matrix (ECM) hydrogel comprising of collagen, laminin-511 E8 fragments and hyaluronic acid optimized to support patient-derived xenograft (PDX) studies. A PDX model uses a patient's tumor tissue to create a growing tumor in an immunodeficient mouse. They retain the histological and genetic characteristics of the patient’s original tumor, [...]
January 22, 2025
News Summary: New and proprietary product enabling laboratories to analyze atmosphere-sensitive materials used to develop batteries, advanced polymers, and medicines in a standard laboratory benchtop-installed thermogravimetric analyzer (TGA). Reduces the cost and footprint of the TGA system by up to 50%i by helping eliminate the need for environment-controlled housing, or glovebox. Enables laboratories to increase throughput without [...]
Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo
January 22, 2025
Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery Company also announces key accreditations in recognition of excellence in data security, AI innovation, and commitment to continuous improvement Palo Alto CA, USA: Artificial, Inc (“Artificial”), a technology company providing cloud-based solutions to streamline [...]
Smiths Detection lightweight chemical detectors (LCD) selected by Japan Ministry of Defence
January 22, 2025
Hundreds of LCD 4 personal detectors to be deployed in the Japan Ground Self-Defence Force Smiths Detection, a global leader in threat detection and security screening technologies is to supply LCD 4 personal chemical detectors to the Japan Ministry of Defence (JMOD) for deployment via its Ground Self-Defence Force (JGSDF). Following an extensive and competitive [...]
January 22, 2025
Industry partners to provide funding and data to support ACAT™ model improvements RESEARCH TRIANGLE, N.C. -- Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that it has entered a new funded collaboration with the Enabling Technologies Consortium [...]
January 22, 2025
ALAMEDA, Calif. -- CellFE, a leader in non-viral gene editing technology, today announced the launch of its highly anticipated CellFE T-Rest ("Resting T Cell Kit"), a first-in-class cell manufacturing transfection media product designed specifically for resting (quiescent) T cell workflows. The novel T-Rest supports a fully optimized gene editing workflow that utilizes resting T cells as [...]

